Approximately 270 new cases of cervical cancer recorded annually in Armenia
Around 270 new cases of cervical cancer are registered in Armenia every year, the majority of which are detected in the late stages—third and fourth—of the disease. It is noted that approximately 115 women die from this type of cancer annually.
According to data from the RA Ministry of Health, the prevalence and mortality rates of cervical cancer in the region are 10 times higher than in Western Europe. The most common cause of cervical cancer is the Human Papillomavirus (HPV), particularly certain high-risk types. Long-term presence of the virus can lead to precancerous cellular changes, which can transform into cancer over the years. The virus is primarily transmitted sexually.
One of the best prevention methods is the HPV vaccine, which is available in Armenia for both girls and boys starting from the age of 13. The efficacy of the vaccine is 99%.
Screening examinations are used for the early detection of cervical cancer: cytological examination (Pap test) is performed once every 3 years, HPV testing once every 5 years, or a combined screening (co-testing) can be performed once every 5 years.
In Armenia, at Primary Health Care facilities, HPV testing is provided free of charge for women aged 30–60 once every 5 years.